Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: Parkinsonism Relat Disord. 2024 Jan 4;120:105991. doi: 10.1016/j.parkreldis.2024.105991

Table 1.

Clinical data of all participants

Control Group
(n = 26)
XDP Group
(n = 26)
Demographic Data
Evaluation Age, M (SD; range) 38.58 (11.41; 22–63) 42.59 (10.28; 25–69)
Diagnosis Age, M (SD; range) Not applicable 38.88 (9.97; 18–64)
XDP Duration, M (SD; range) Not applicable 4.38 years (4.87; 0–21)
Clinical Data
M SD M SD
MDS-UPDRS
 Part 1 2.40 2.51 7.67 6.92
 Part 2 .33 .88 16.11 11.15
 Part 3 3.97 3.63 34.17 15.15
 Part 4 0 0 3.76 3.31
BFM
 Movement 0 0 21.89 21.47
 Disability .04 .20 8.13 5.11
TWSTRS
 Disability 0 0 6.39 9.58
 Pain 0 0 2.95 4.40
XDP Phenotype Present at Data Collection
n %
Dystoni a-Dominant 0 0
Parkinsonism-Dominant 0 0
Mixed Dystonia-Parkinsonism 26 100
Symptom at Data Collection
n % n %
Dystonia
 Bulbar Not present Not present 13 50.0
 Non-bulbar Not present Not present 2 7.60
 Unspecified Not present Not present 11 42.31
Parkinsonism
 Bulbar Not present Not present 11 42.31
 Non-bulbar Not present Not present 3 11.54
 Unspecified Not present Not present 12 46.15